{"basic_info": {"ticker": "8247", "exchange": "XHKG", "bloomberg_ticker": "8247 HK Equity", "name": "BIOSINO BIO-TECHNOLOGY -H", "industry": "Biotechnology", "name_chinese_simplified": "中生北控生物科技", "period": "2020", "market_value": 243108048, "total_income": 325256000, "ccy": "人民币元", "shariah_compliance_summary": "non-compliant"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 325256000, "business_income_over_total_income": 1.0}, {"shariah_compliance": "unknown", "income": 0, "business_income_over_total_income": 0.0}], "details": [{"business_activity_cn": "销售体外诊断试剂产品", "business_activity_en": "Sales in vitro diagnostic reagent products", "income": 325256000, "business_income_over_total_income": 1.0, "shariah_compliance": "compliant"}, {"business_activity_cn": "未分配", "business_activity_en": "Unassigned", "income": 0, "business_income_over_total_income": 0.0, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 1.3284986766739648, "shariah_compliance": "non-compliant", "amount_over_market_value": 1.3284986766739648}]}